返回 Agenda
Benefit/Risk Communication: Towards a Patient-Centred Approach
Session Chair(s)
Ragnar Lofstedt, PHD, MA
Professor of Risk Management
Kings College London, United Kingdom
Regulatory agencies and pharmaceutical companies across the Atlantic have shown a large appetite for identifying and developing effective benefit/risk communication towards patients, healthcare professionals and the general public. This panel discussion will assemble representatives from all major parties involved to assess the progress achieved and suggest concrete ways to further improve benefit/risk communication.
Speaker(s)
Panel Discussion
Francesco Pignatti, MD
European Medicines Agency, Netherlands
Scientific Adviser for Oncology
Panel Discussion
Frederic Bouder, PHD
University of Stavanger, Norway
Professor in Risk Management
Panel Discussion
David Haerry
EATG, Switzerland
Patient Advocate